Enlivex Therapeutics Statistics
Total Valuation
ENLV has a market cap or net worth of $26.95 million. The enterprise value is -$365,805.
| Market Cap | 26.95M |
| Enterprise Value | -365,805 |
Important Dates
The last earnings date was Friday, March 29, 2024, after market close.
| Earnings Date | Mar 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ENLV has 18.59 million shares outstanding.
| Shares Outstanding | 18.59M |
| Owned by Insiders (%) | 11.81% |
| Owned by Institutions (%) | 8.93% |
| Float | 14.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.90 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.57, with zero debt.
| Current Ratio | 5.57 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 89.89 |
Financial Efficiency
Return on equity (ROE) is -71.00% and return on invested capital (ROIC) is -97.71%.
| Return on Equity (ROE) | -71.00% |
| Return on Assets (ROA) | -59.10% |
| Return on Capital (ROIC) | -97.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$409,408 |
| Employee Count | 71 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.03% in the last 52 weeks. The beta is 1.06, so ENLV's price volatility has been similar to the market average.
| Beta (1Y) | 1.06 |
| 52-Week Price Change | -48.03% |
| 50-Day Moving Average | 3.18 |
| 200-Day Moving Average | 2.42 |
| Relative Strength Index (RSI) | 30.75 |
| Average Volume (30 Days) | 173,354 |
Short Selling Information
| Short Interest | 278,652 |
| Short Previous Month | 236,381 |
| Short % of Shares Out | 1.60% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.87 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.40M |
| Pretax Income | -29.07M |
| Net Income | -29.07M |
| EBITDA | -28.56M |
| EBIT | -29.40M |
| Earnings Per Share (EPS) | -$1.56 |
Balance Sheet
The company has $27.32 million in cash and no debt, giving a net cash position of $27.32 million or $1.47 per share.
| Cash & Cash Equivalents | 27.32M |
| Total Debt | n/a |
| Net Cash | 27.32M |
| Net Cash Per Share | $1.47 |
| Equity / Book Value | 30.08M |
| Book Value Per Share | 1.62 |
| Working Capital | 27.70M |
Cash Flow
In the last 12 months, operating cash flow was -$23.52 million and capital expenditures -$103,000, giving a free cash flow of -$23.63 million.
| Operating Cash Flow | -23.52M |
| Capital Expenditures | -103,000 |
| Free Cash Flow | -23.63M |
| FCF Per Share | -$1.27 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENLV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.98% |
| Shareholder Yield | -0.98% |
| Earnings Yield | -107.84% |
| FCF Yield | -87.65% |
Analyst Forecast
The average price target for ENLV is $7.00, which is 382.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 382.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 6, 2019. It was a reverse split with a ratio of 1:8.
| Last Split Date | Mar 6, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |